Format

Send to

Choose Destination
Curr Opin Mol Ther. 2001 Feb;3(1):77-84.

Chemotherapy: friend or foe to cancer vaccines?

Author information

1
Johns Hopkins University School of Medicine, Department of Oncology, Baltimore, MD 21231, USA. ejaffee@jhmi.edu

Abstract

Cancer vaccines are on the threshold of taking their place alongside the more traditional cancer treatment modalities of surgery, radiation therapy and chemotherapy. The toxicology and immunopharmacology of therapeutic cancer vaccines, particularly those that secrete granulocyte macrophage colony stimulating factor (GM-CSF), are currently under active clinical investigation. Interestingly, drugs traditionally used for tumor cytoreduction can have both positive and negative effects on host immunity. Exploration of the potential pharmacodynamic interactions of antineoplastic drugs with GM-CSF-secreting vaccines has revealed that low doses of some chemotherapeutics can augment the antitumor immunity induced by GM-CSF-secreting vaccines. These interactions will require thorough preclinical evaluation to maximize the clinical impact of this type of therapeutic cancer vaccine.

PMID:
11249735
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center